chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 58.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Axillary pain, Chills, Fatigue, Lymph node pain, Pain
Clinical narrative: Achy; Tired; Chills; Had pain in by left arm pit nearbreast and lymph nodes; Pain in lymph nodes; This is a spontaneous report from a contactable consumer, the patient. A 58-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 03Apr2021 at 14:15 (at the age of 58-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19. The patient was not allergic to medications, food, or other products. Concomitant medications included vitamin d nos (VITAMIN D), HEALTH CONCERNS NASAL CAPS and multivitamin (MANUFACTURER UNKNOWN).  Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 04Apr2021 at 14:15, 24 hours after receiving shot, the patient started to feel achy, tired, got the chills, pain in left arm pit near breast and lymph nodes. All the symptoms went away within 2 or 3 days. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care visit. Therapeutic measures were not taken as a result of the event. The clinical outcome of the events felt achy, tired, got the chills and had pain in by left arm pit near breast and lymph nodes were recovered on an unknown date in Apr2021.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 32.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Muscle twitching
Clinical narrative: Muscle twitches in my right arm and right leg; woken up from sleep; This is a spontaneous report from a contactable consumer, the patient. A 32-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW01050) via an unspecified route of administration in the left arm on 05Apr2021 at 16:15 (at the age of 32-year-old) as a single dose for COVID-19 immunisation. Medical history included none. The patient did not have any allergies to medications, food, or other products. Concomitant medications included cannabidiol (CBD OIL) for an unknown indication from an unknown date. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 05Apr2021 at 20:45, about 4-5 hours later, the patient started having muscle twitches in right arm and right leg. This continued for five days. It was not severe by any means, just happened often throughout the day and had woken up from sleep. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events muscle twitches and woken up from sleep was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 32.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Muscle twitching, Sleep disorder
Clinical narrative: Muscle twitches in my right arm and right leg; woken up from sleep; This is a spontaneous report from a contactable consumer, the patient. A 32-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW01050) via an unspecified route of administration in the left arm on 05Apr2021 at 16:15 (at the age of 32-year-old) as a single dose for COVID-19 immunisation. Medical history included none. The patient did not have any allergies to medications, food, or other products. Concomitant medications included cannabidiol (CBD OIL) for an unknown indication from an unknown date. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 05Apr2021 at 20:45, about 4-5 hours later, the patient started having muscle twitches in right arm and right leg. This continued for five days. It was not severe by any means, just happened often throughout the day and had woken up from sleep. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events muscle twitches and woken up from sleep was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Sex: U
Vaccine: UNK, COVID19
Symptoms: Rash, Rash erythematous, Rash pruritic, Skin warm
Clinical narrative: Red hot rash on left arm and on the right side of my face; Terribly itchy; This is a spontaneous report from a contactable consumer, the patient. A 71-year-old patient of unknown gender patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 05Apr2021 at 12:45 as a single dose for COVID-19 immunisation. Medical history included COVID 19, allergic to latex, paper tape and too many to list. Concomitant medication included too many to list(unspecified) within 2 weeks of vaccination. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via an unspecified route of administration in the left arm on 14Mar2021 at 11:30 as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient received any other unspecified vaccines within four weeks prior to the COVID vaccine. On 07Apr2021 (2 days after vaccine), the patient had a terribly itchy, red hot rash on left arm and now the patient had the same patch on the right side of my face. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events had a terribly itchy, red hot rash on left arm and now the patient had the same patch on the right side of my face was not recovered at the time of this report.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Sex: U
Vaccine: UNK, COVID19
Symptoms: Pruritus, Rash erythematous
Clinical narrative: Red hot rash on left arm and on the right side of my face; Terribly itchy; This is a spontaneous report from a contactable consumer, the patient. A 71-year-old patient of unknown gender patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 05Apr2021 at 12:45 as a single dose for COVID-19 immunisation. Medical history included COVID 19, allergic to latex, paper tape and too many to list. Concomitant medication included too many to list(unspecified) within 2 weeks of vaccination. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via an unspecified route of administration in the left arm on 14Mar2021 at 11:30 as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient received any other unspecified vaccines within four weeks prior to the COVID vaccine. On 07Apr2021 (2 days after vaccine), the patient had a terribly itchy, red hot rash on left arm and now the patient had the same patch on the right side of my face. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events had a terribly itchy, red hot rash on left arm and now the patient had the same patch on the right side of my face was not recovered at the time of this report.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 54.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Erythema of eyelid, Swelling of eyelid, Vision blurred
Clinical narrative: Right eyelid is a bit red and puffy; Right eyelid is a bit red and puffy; Slightly blurred vision; This is a spontaneous report from a contactable consumer, the patient. A 54-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0153) via an unspecified route of administration in the arm left on 07Apr2021 at 16:45(at the age of 54-year-old) as a single dose for COVID-19 immunisation. Medical history included fibromyalgia, migraine, allergy, chronic pain and penicillin allergy. Concomitant medications included tramadol (MANUFACTURER UNKNOWN), levothyroxine sodium (SYNTHROID), tizanidine (MANUFACTURER UNKNOWN) and trazodone (MANUFACTURER UNKNOWN) for unknown indications and from an unknown date. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER2613) via an unspecified route of administration in the arm left on 17Mar2021 at 16:30 (at the age of 54-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 07Apr2021 at 17:15, the patient experienced slightly blurred vision and on 09Apr2021, Saturday the patient's right eyelid was a bit red and puffy. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were taken as a result of the events which included treatment with fexofenadine (ALLEGRA) and a cold compress which seemed to gave some relief. The clinical outcome of the events slightly blurred vision, right eyelid was a bit red and puffy were resolving at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 54.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Erythema of eyelid, Eyelid oedema, Vision blurred
Clinical narrative: Right eyelid is a bit red and puffy; Right eyelid is a bit red and puffy; Slightly blurred vision; This is a spontaneous report from a contactable consumer, the patient. A 54-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0153) via an unspecified route of administration in the arm left on 07Apr2021 at 16:45(at the age of 54-year-old) as a single dose for COVID-19 immunisation. Medical history included fibromyalgia, migraine, allergy, chronic pain and penicillin allergy. Concomitant medications included tramadol (MANUFACTURER UNKNOWN), levothyroxine sodium (SYNTHROID), tizanidine (MANUFACTURER UNKNOWN) and trazodone (MANUFACTURER UNKNOWN) for unknown indications and from an unknown date. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER2613) via an unspecified route of administration in the arm left on 17Mar2021 at 16:30 (at the age of 54-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 07Apr2021 at 17:15, the patient experienced slightly blurred vision and on 09Apr2021, Saturday the patient's right eyelid was a bit red and puffy. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were taken as a result of the events which included treatment with fexofenadine (ALLEGRA) and a cold compress which seemed to gave some relief. The clinical outcome of the events slightly blurred vision, right eyelid was a bit red and puffy were resolving at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 58.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Blood glucose decreased, Confusional state, Diarrhoea, Feeling abnormal, Rash
Clinical narrative: Red rash across arms, legs and belly; Terrible diarrhea; This is a spontaneous report from a contactable consumer, the patient. A 58-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 08Apr2021 at 11:30 (at the age of 58-years-old) as a single dose for COVID-19 immunisation. Medical history included obesity and borderline hypoglycemia. The patient had no known allergies to medications, food, or other products. Concomitant medications included naproxen (NAPROSYN) for an unknow indication from an unknown date. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On 08Apr2021 at 23:30, about 12 hours after the vaccine, the patient experienced terrible diarrhea which lasted for several hours. On 09Apr2021, the patient had a red rash across his arms, legs and belly. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events red rash across arms, legs and belly and terrible diarrhea was resolving at the time of this report.   No follow-up attempts are needed; information about lot number cannot be obtained. No further information is expected.
Age: 58.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Rash erythematous
Clinical narrative: Red rash across arms, legs and belly; Terrible diarrhea; This is a spontaneous report from a contactable consumer, the patient. A 58-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 08Apr2021 at 11:30 (at the age of 58-years-old) as a single dose for COVID-19 immunisation. Medical history included obesity and borderline hypoglycemia. The patient had no known allergies to medications, food, or other products. Concomitant medications included naproxen (NAPROSYN) for an unknow indication from an unknown date. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On 08Apr2021 at 23:30, about 12 hours after the vaccine, the patient experienced terrible diarrhea which lasted for several hours. On 09Apr2021, the patient had a red rash across his arms, legs and belly. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events red rash across arms, legs and belly and terrible diarrhea was resolving at the time of this report.   No follow-up attempts are needed; information about lot number cannot be obtained. No further information is expected.
Age: 58.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Diarrhoea, Rash erythematous
Clinical narrative: Red rash across arms, legs and belly; Terrible diarrhea; This is a spontaneous report from a contactable consumer, the patient. A 58-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 08Apr2021 at 11:30 (at the age of 58-years-old) as a single dose for COVID-19 immunisation. Medical history included obesity and borderline hypoglycemia. The patient had no known allergies to medications, food, or other products. Concomitant medications included naproxen (NAPROSYN) for an unknow indication from an unknown date. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On 08Apr2021 at 23:30, about 12 hours after the vaccine, the patient experienced terrible diarrhea which lasted for several hours. On 09Apr2021, the patient had a red rash across his arms, legs and belly. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events red rash across arms, legs and belly and terrible diarrhea was resolving at the time of this report.   No follow-up attempts are needed; information about lot number cannot be obtained. No further information is expected.
Age: 62.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chills, Diarrhoea, Pyrexia
Clinical narrative: Fever since the day after the vaccination (6 days); This is a spontaneous report from a contactable consumer, the patient. A 62-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 04Apr2021 at 14:30 (at the age of 62-years-old) as a single dose for COVID-19 immunisation. Medical history included none. The patient did not receive any medication within two weeks of vaccination. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 05Apr2021, the patient experienced fever since the day after the vaccination (6 days). The patient did not receive any treatment for the event. On 10Apr2021, the patient underwent a nasal swab test for COVID-19 and the result was Negative. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event fever since the day after the vaccination (6 days) was not recovered.    No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 62.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pyrexia, SARS-CoV-2 test
Clinical narrative: Fever since the day after the vaccination (6 days); This is a spontaneous report from a contactable consumer, the patient. A 62-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 04Apr2021 at 14:30 (at the age of 62-years-old) as a single dose for COVID-19 immunisation. Medical history included none. The patient did not receive any medication within two weeks of vaccination. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 05Apr2021, the patient experienced fever since the day after the vaccination (6 days). The patient did not receive any treatment for the event. On 10Apr2021, the patient underwent a nasal swab test for COVID-19 and the result was Negative. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event fever since the day after the vaccination (6 days) was not recovered.    No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 46.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dysmenorrhoea, Heavy menstrual bleeding, Limb discomfort, Menstrual disorder, Pain in extremity
Clinical narrative: Painful cramps; started my menstrual cycle - 2 weeks early. I am on birth control and have not had a period out of schedule since I started on the pill in my 20's.; extremely heavy with painful cramps -which I have not had since starting on the pill in my 20's; Left arm from shoulder down to elbow was very painful; Left arm from shoulder down to elbow was very painful; Left arm from shoulder down to elbow was very painful and felt very heavy for a few days; This is a spontaneous report from a contactable consumer, the patient. A 46-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7534), via an unspecified route of administration in the left arm on 07Apr2021 at 16:00 (at the age of 46-years-old), as a single dose for COVID-19 immunisation. Medical history included high blood pressure, seasonal allergy and food allergy (lactose intolerant). The patient receives unspecified medications within two weeks of vaccination. The patient previously took codeine, percocet and neosporin; all on unknown dates for unspecified indications and experienced drug allergy. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6208), via an unspecified route of administration in the left arm on 18Mar2021 at 14:30 (at the age of 46-years-old), as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 07Apr2021, the patient experienced left arm from shoulder down to elbow was very painful, felt very heavy for a few days. The patient had to keep ice pack on it all day/night. On 08Apr2021, day after second dose, the patient started her menstrual cycle- 2 weeks early, the patient was on birth control and have not had a period out of the schedule since she started on the pill in her 20's. It has also been extremely heavy with painful cramps-which she has not had since starting on the pill in her 20's. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events left arm from shoulder down to elbow was very painful, felt very heavy for a few days, started her menstrual cycle- 2 weeks early, it has also been extremely heavy with painful cramps were not recovered at the time of reporting.   No follow-up attempts are needed. No further information is expected.
Age: 46.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Dysmenorrhoea, Heavy menstrual bleeding, Limb discomfort, Menstruation irregular
Clinical narrative: Painful cramps; started my menstrual cycle - 2 weeks early. I am on birth control and have not had a period out of schedule since I started on the pill in my 20's.; extremely heavy with painful cramps -which I have not had since starting on the pill in my 20's; Left arm from shoulder down to elbow was very painful; Left arm from shoulder down to elbow was very painful; Left arm from shoulder down to elbow was very painful and felt very heavy for a few days; This is a spontaneous report from a contactable consumer, the patient. A 46-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7534), via an unspecified route of administration in the left arm on 07Apr2021 at 16:00 (at the age of 46-years-old), as a single dose for COVID-19 immunisation. Medical history included high blood pressure, seasonal allergy and food allergy (lactose intolerant). The patient receives unspecified medications within two weeks of vaccination. The patient previously took codeine, percocet and neosporin; all on unknown dates for unspecified indications and experienced drug allergy. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6208), via an unspecified route of administration in the left arm on 18Mar2021 at 14:30 (at the age of 46-years-old), as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 07Apr2021, the patient experienced left arm from shoulder down to elbow was very painful, felt very heavy for a few days. The patient had to keep ice pack on it all day/night. On 08Apr2021, day after second dose, the patient started her menstrual cycle- 2 weeks early, the patient was on birth control and have not had a period out of the schedule since she started on the pill in her 20's. It has also been extremely heavy with painful cramps-which she has not had since starting on the pill in her 20's. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events left arm from shoulder down to elbow was very painful, felt very heavy for a few days, started her menstrual cycle- 2 weeks early, it has also been extremely heavy with painful cramps were not recovered at the time of reporting.   No follow-up attempts are needed. No further information is expected.
Age: 37.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Arthralgia, Blood pressure increased, Disorientation, Dizziness, Fatigue
Clinical narrative: muscle weakness; fatigue; low grade fever; dizziness; joint pain; constantheadache/pressure & tension; neck stiffness; nausea; heat around head and neck; constant headache; This is a spontaneous report from a contactable healthcare professional, the patient. A 37-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8734), via an unspecified route of administration in the left arm on 04Apr2021 (at the age of 37-year-old), as a single dose for COVID-19 immunisation. Medical history included sleep apnea, herniated disc C5-C6, rotator cuff impingement, reflux, seasonal allergies, anaemia. Th patient had a history of allergies to penicillin, sulfa, codeine and prednisone. Concomitant medications included paracetamol (ACETAMINOPHEN), ibuprofen (MANUFACTURER UNKNOWN), calcium carbonate; magnesium carbonate (TUMS), tilactase (LACTAID), pyridoxine hydrochloride; biotin; tocopherol; folic acid; colecalciferol; cyanocobalamin; riboflavin; nicotinamide; thiamine mononitrate; magnesium oxide; zinc oxide; calcium ascorbate; iron; calcium; potassium iodide; copper sulfate; fish oil (OB COMPLETE ONE) and colecalciferol (VITAMIN D3) 50k IU all for an unknown indication from an unknown date and received 3 dry needling sessions from DPT due to herniated disc twice before and once after second dose and unable to list all the drug on previous form. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6202), via an unspecified route of administration in the left arm on 14Mar2021 (at the age of 37-year-old), as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 05Apr2021, the patient experienced muscle weakness, fatigue low grade fever, dizziness, joint pain, constant headache/pressure & tension, neck stiffness, nausea, heat around head/neck. The event resulted in doctor or other healthcare professional office/clinic visit. No therapeutic measures were taken for the events. On 08Apr2021, the patient underwent COVID-19 (Nasal Swab) test and the result was negative. The clinical outcome of the event muscle weakness, fatigue low grade fever, dizziness, joint pain, constant headache/pressure & tension, neck stiffness, nausea, heat around head/neck was ongoing at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 37.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Feeling hot, Head discomfort, Headache, Nausea, Pyrexia
Clinical narrative: muscle weakness; fatigue; low grade fever; dizziness; joint pain; constantheadache/pressure & tension; neck stiffness; nausea; heat around head and neck; constant headache; This is a spontaneous report from a contactable healthcare professional, the patient. A 37-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8734), via an unspecified route of administration in the left arm on 04Apr2021 (at the age of 37-year-old), as a single dose for COVID-19 immunisation. Medical history included sleep apnea, herniated disc C5-C6, rotator cuff impingement, reflux, seasonal allergies, anaemia. Th patient had a history of allergies to penicillin, sulfa, codeine and prednisone. Concomitant medications included paracetamol (ACETAMINOPHEN), ibuprofen (MANUFACTURER UNKNOWN), calcium carbonate; magnesium carbonate (TUMS), tilactase (LACTAID), pyridoxine hydrochloride; biotin; tocopherol; folic acid; colecalciferol; cyanocobalamin; riboflavin; nicotinamide; thiamine mononitrate; magnesium oxide; zinc oxide; calcium ascorbate; iron; calcium; potassium iodide; copper sulfate; fish oil (OB COMPLETE ONE) and colecalciferol (VITAMIN D3) 50k IU all for an unknown indication from an unknown date and received 3 dry needling sessions from DPT due to herniated disc twice before and once after second dose and unable to list all the drug on previous form. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6202), via an unspecified route of administration in the left arm on 14Mar2021 (at the age of 37-year-old), as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 05Apr2021, the patient experienced muscle weakness, fatigue low grade fever, dizziness, joint pain, constant headache/pressure & tension, neck stiffness, nausea, heat around head/neck. The event resulted in doctor or other healthcare professional office/clinic visit. No therapeutic measures were taken for the events. On 08Apr2021, the patient underwent COVID-19 (Nasal Swab) test and the result was negative. The clinical outcome of the event muscle weakness, fatigue low grade fever, dizziness, joint pain, constant headache/pressure & tension, neck stiffness, nausea, heat around head/neck was ongoing at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 37.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: SARS-CoV-2 test negative, Tension
Clinical narrative: muscle weakness; fatigue; low grade fever; dizziness; joint pain; constantheadache/pressure & tension; neck stiffness; nausea; heat around head and neck; constant headache; This is a spontaneous report from a contactable healthcare professional, the patient. A 37-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8734), via an unspecified route of administration in the left arm on 04Apr2021 (at the age of 37-year-old), as a single dose for COVID-19 immunisation. Medical history included sleep apnea, herniated disc C5-C6, rotator cuff impingement, reflux, seasonal allergies, anaemia. Th patient had a history of allergies to penicillin, sulfa, codeine and prednisone. Concomitant medications included paracetamol (ACETAMINOPHEN), ibuprofen (MANUFACTURER UNKNOWN), calcium carbonate; magnesium carbonate (TUMS), tilactase (LACTAID), pyridoxine hydrochloride; biotin; tocopherol; folic acid; colecalciferol; cyanocobalamin; riboflavin; nicotinamide; thiamine mononitrate; magnesium oxide; zinc oxide; calcium ascorbate; iron; calcium; potassium iodide; copper sulfate; fish oil (OB COMPLETE ONE) and colecalciferol (VITAMIN D3) 50k IU all for an unknown indication from an unknown date and received 3 dry needling sessions from DPT due to herniated disc twice before and once after second dose and unable to list all the drug on previous form. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6202), via an unspecified route of administration in the left arm on 14Mar2021 (at the age of 37-year-old), as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 05Apr2021, the patient experienced muscle weakness, fatigue low grade fever, dizziness, joint pain, constant headache/pressure & tension, neck stiffness, nausea, heat around head/neck. The event resulted in doctor or other healthcare professional office/clinic visit. No therapeutic measures were taken for the events. On 08Apr2021, the patient underwent COVID-19 (Nasal Swab) test and the result was negative. The clinical outcome of the event muscle weakness, fatigue low grade fever, dizziness, joint pain, constant headache/pressure & tension, neck stiffness, nausea, heat around head/neck was ongoing at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 37.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Arthralgia, Dizziness, Fatigue, Feeling hot, Headache
Clinical narrative: muscle weakness; fatigue; low grade fever; dizziness; joint pain; constantheadache/pressure & tension; neck stiffness; nausea; heat around head and neck; constant headache; This is a spontaneous report from a contactable healthcare professional, the patient. A 37-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8734), via an unspecified route of administration in the left arm on 04Apr2021 (at the age of 37-year-old), as a single dose for COVID-19 immunisation. Medical history included sleep apnea, herniated disc C5-C6, rotator cuff impingement, reflux, seasonal allergies, anaemia. Th patient had a history of allergies to penicillin, sulfa, codeine and prednisone. Concomitant medications included paracetamol (ACETAMINOPHEN), ibuprofen (MANUFACTURER UNKNOWN), calcium carbonate; magnesium carbonate (TUMS), tilactase (LACTAID), pyridoxine hydrochloride; biotin; tocopherol; folic acid; colecalciferol; cyanocobalamin; riboflavin; nicotinamide; thiamine mononitrate; magnesium oxide; zinc oxide; calcium ascorbate; iron; calcium; potassium iodide; copper sulfate; fish oil (OB COMPLETE ONE) and colecalciferol (VITAMIN D3) 50k IU all for an unknown indication from an unknown date and received 3 dry needling sessions from DPT due to herniated disc twice before and once after second dose and unable to list all the drug on previous form. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6202), via an unspecified route of administration in the left arm on 14Mar2021 (at the age of 37-year-old), as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 05Apr2021, the patient experienced muscle weakness, fatigue low grade fever, dizziness, joint pain, constant headache/pressure & tension, neck stiffness, nausea, heat around head/neck. The event resulted in doctor or other healthcare professional office/clinic visit. No therapeutic measures were taken for the events. On 08Apr2021, the patient underwent COVID-19 (Nasal Swab) test and the result was negative. The clinical outcome of the event muscle weakness, fatigue low grade fever, dizziness, joint pain, constant headache/pressure & tension, neck stiffness, nausea, heat around head/neck was ongoing at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 37.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Muscular weakness, Musculoskeletal stiffness, Nausea, Pyrexia, SARS-CoV-2 test
Clinical narrative: muscle weakness; fatigue; low grade fever; dizziness; joint pain; constantheadache/pressure & tension; neck stiffness; nausea; heat around head and neck; constant headache; This is a spontaneous report from a contactable healthcare professional, the patient. A 37-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8734), via an unspecified route of administration in the left arm on 04Apr2021 (at the age of 37-year-old), as a single dose for COVID-19 immunisation. Medical history included sleep apnea, herniated disc C5-C6, rotator cuff impingement, reflux, seasonal allergies, anaemia. Th patient had a history of allergies to penicillin, sulfa, codeine and prednisone. Concomitant medications included paracetamol (ACETAMINOPHEN), ibuprofen (MANUFACTURER UNKNOWN), calcium carbonate; magnesium carbonate (TUMS), tilactase (LACTAID), pyridoxine hydrochloride; biotin; tocopherol; folic acid; colecalciferol; cyanocobalamin; riboflavin; nicotinamide; thiamine mononitrate; magnesium oxide; zinc oxide; calcium ascorbate; iron; calcium; potassium iodide; copper sulfate; fish oil (OB COMPLETE ONE) and colecalciferol (VITAMIN D3) 50k IU all for an unknown indication from an unknown date and received 3 dry needling sessions from DPT due to herniated disc twice before and once after second dose and unable to list all the drug on previous form. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6202), via an unspecified route of administration in the left arm on 14Mar2021 (at the age of 37-year-old), as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 05Apr2021, the patient experienced muscle weakness, fatigue low grade fever, dizziness, joint pain, constant headache/pressure & tension, neck stiffness, nausea, heat around head/neck. The event resulted in doctor or other healthcare professional office/clinic visit. No therapeutic measures were taken for the events. On 08Apr2021, the patient underwent COVID-19 (Nasal Swab) test and the result was negative. The clinical outcome of the event muscle weakness, fatigue low grade fever, dizziness, joint pain, constant headache/pressure & tension, neck stiffness, nausea, heat around head/neck was ongoing at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 37.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Tension headache
Clinical narrative: muscle weakness; fatigue; low grade fever; dizziness; joint pain; constantheadache/pressure & tension; neck stiffness; nausea; heat around head and neck; constant headache; This is a spontaneous report from a contactable healthcare professional, the patient. A 37-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8734), via an unspecified route of administration in the left arm on 04Apr2021 (at the age of 37-year-old), as a single dose for COVID-19 immunisation. Medical history included sleep apnea, herniated disc C5-C6, rotator cuff impingement, reflux, seasonal allergies, anaemia. Th patient had a history of allergies to penicillin, sulfa, codeine and prednisone. Concomitant medications included paracetamol (ACETAMINOPHEN), ibuprofen (MANUFACTURER UNKNOWN), calcium carbonate; magnesium carbonate (TUMS), tilactase (LACTAID), pyridoxine hydrochloride; biotin; tocopherol; folic acid; colecalciferol; cyanocobalamin; riboflavin; nicotinamide; thiamine mononitrate; magnesium oxide; zinc oxide; calcium ascorbate; iron; calcium; potassium iodide; copper sulfate; fish oil (OB COMPLETE ONE) and colecalciferol (VITAMIN D3) 50k IU all for an unknown indication from an unknown date and received 3 dry needling sessions from DPT due to herniated disc twice before and once after second dose and unable to list all the drug on previous form. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6202), via an unspecified route of administration in the left arm on 14Mar2021 (at the age of 37-year-old), as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 05Apr2021, the patient experienced muscle weakness, fatigue low grade fever, dizziness, joint pain, constant headache/pressure & tension, neck stiffness, nausea, heat around head/neck. The event resulted in doctor or other healthcare professional office/clinic visit. No therapeutic measures were taken for the events. On 08Apr2021, the patient underwent COVID-19 (Nasal Swab) test and the result was negative. The clinical outcome of the event muscle weakness, fatigue low grade fever, dizziness, joint pain, constant headache/pressure & tension, neck stiffness, nausea, heat around head/neck was ongoing at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 22.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Cheilitis, Rash, Rash erythematous, Rash pruritic, Urticaria
Clinical narrative: 3 days after the vaccine I woke up with a hives-like rash.; This consists of raised red bumps, ranging is size from about 1 cm to 1/4 cm in diameter. They are specifically concentrated over both my knee caps and both my elbows. From each of these concentrated locations, they continue up and down the limb; This consists of raised red bumps, ranging is size from about 1 cm to 1/4 cm in diameter. They are specifically concentrated over both my knee caps and both my elbows. From each of these concentrated locations, they continue up and down the limb; I also have redness around the edge of my ears.; All bumps are itchy when touched, but not unbearable otherwise; This is a spontaneous report from a contactable consumer, the patient. A 22-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 07Apr2021 at 08:45 (at the age of 22-years-old) as a single dose for COVID-19 immunisation. The patient previously has had a photosensitivity allergic reaction (reported as sun allergy). Concomitant medications taken within two weeks prior to vaccination included Birth control (unspecified), paracetamol (manufacturer: TYLENOL), ibuprofen (manufacturer: ADVIL) and amoxicillin (MANUFACTURER UNKNOWN), all from unknown date for unknown indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 10Apr2021 at 04:00, three days after the vaccine, the patient woke up with a hives-like rash. This consisted of raised red bumps, ranging in size from about 1 centimeter to 1/4 centimeter in diameter. They were specifically concentrated over both her knee caps and both her elbows. From each of these concentrated locations, they continued up and down the limb. The patient also had redness around the edge of her ears. All bumps were itchy when touched, but not unbearable otherwise. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. It was unknown whether therapeutic measures were taken as a result of the events. The clinical outcome of the events three days after the vaccine, the patient woke up with a hives-like rash that consisted of raised red bumps, ranging in size from about 1 cm to 1/4 cm in diameter and were specifically concentrated over both her knee caps and both her elbows; from each of these concentrated locations, they continued up and down the limb and redness around the edge of her ears, all bumps were itchy when touched, but not unbearable otherwise was unknown at the time of this report.  No follow-up attempts are needed; information about lot/batch number cannot be obtained. No further information is expected